RUBICON TECHNOLOGY LAUNCHES DIRECT DOSE RX - A DIRECT TO PATIENT PHARMACY SOLUTION

Stock Information for Rubicon Technology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Rubicon Technology Inc.

Rubicon Technology Announces Voluntary Delisting from Nasdaq
Rubicon Technology, Inc. Sets Record Date for its $11.00 per share Cash Distribution
Equity Alert - The M&A Class Action Firm Announces the Investigation of Rubicon Technology, Inc. - RBCN
Rubicon Technology, Inc. Investors: Company Investigated by the Portnoy Law Firm
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Rubicon Technology, Inc. with Losses to Contact the Firm
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Rubicon Technology, Inc. with Losses to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Rubicon Technology, Inc. with Losses to Contact the Firm
Janel Corporation to Launch a Cash Tender Offer to Acquire a 45% Interest in Rubicon Technology, Inc. at $20 Per Share

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.